A Rollover Protocol to Provide Subjects Completing the FTC-203 Study in South Africa With Continued Access to Emtricitabine.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Emtricitabine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 21 Feb 2017 Status changed from active, no longer recruiting to completed.
- 17 Sep 2008 New trial record.